AVISE CTD
Commercial- Indications
- Connective tissue disease
Company intelligence / Profile preview
Exagen
Vista, California, United Statesavisetest.com ↗
- Ownership
- Public · XGN
- Development stage
- Commercial
01
Overview
Exagen develops and commercializes laboratory diagnostic solutions focused on autoimmune diseases. Its AVISE product line includes tools for differential diagnosis of connective tissue diseases, prognosis of systemic lupus erythematosus complications, and monitoring of SLE activity using proprietary biomarker technologies. These diagnostics are used clinically to improve patient management in rheumatology settings. The company reports strong financial results as a commercial-stage entity.
- Therapeutic areas
- ImmunologyRheumatology
- Modalities
- Diagnostic test (laboratory-developed tests)Device (diagnostic platform)Small molecule (anti-TNF therapeutic for at-home use)
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Financials
- Market cap
- $176.4M
- Total revenue
- $19.9M
- Enterprise value
- $177.3M
Beyond the preview
Go deeper on Exagen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exagen.